Diabetes clinic

Effectiveness and Safety of Losarten in the Management of Essential Hypertension: A Prospective Cohort Study. Can J Diagnosis. Vol 24, No 4, April 2007

Clinical Focus: Diabetes in Canada. Medical Post (Suppl) June 22 2007

Clinical Focus: Insulin Pump Therapy. Medical Post (Suppl) July 2007

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet. Med. 2006 Jul;23(7):736-42.

Sexual Dysfunction in Diabetes. Canadian Diabetes. 19(1), Spring 2006 (Editorial)

Peri-Op & Peri-ACS Glucose Control. Canadian Diabetes, 18(2),Summer 2005 (Editorial)

Diabetes Flow Sheet with Feedback to Improve CPG Compliance. Canadian Journal of Diabetes. 2004 Sep, Vol 28 No 3, P 314

Practical Application of Rosiglitazone in Clinical Practice. Diabetes 2004 June, Vol 53, Suppl 1 A121 (Abstract)

2003 CDA Clinical Practice Guidelines, are they achievable. Canadian Journal of Diabetes 2003 Sept (Abstract)

The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006;151:786.e1-10.

Advances in management options for insulin-dependent patients. The Medical Post. 12 June 2007; 43(21):(centerfold)

Practical Application of Rosiglitazone in Clinical Practice. Diabetes & Metabolism 2003,29,4S246, Abstract 22772

Effectiveness of Rosiglitazone in Family Practice in Canada. Diabetes & Metabolism 2003,29,4S246, Abstract 2274

A Community Based Insulin Pump Program. Diabetes 2003;52 (Suppl 1) A518 Abstract 2246-PO

Option or Essential Tool? Insulin Pump Therapy in Young Women. Diabetes, June 2002, Suppl

Guidelines, Do They Make a Difference? Canadian Journal of Diabetes. 2002;26(suppl):256.

Community Based Insulin Pump Program Outcomes. Canadian Journal of Diabetes.2002;26(suppl);272.

Pioglitazone in Family Practice. Canadian Journal of Diabetes. 2002;26(suppl);308.

Rosiglitazone in Family Practice. Canadian Journal of Diabetes. 2002;26 (suppl);308

Rosiglitazone in Family Practice. Diabetes, June 2001, Suppl

Insulin Resistance in Diabetes Mellitus. Medical Post, Nov 2001, Suppl

Rosiglitazone in Family Practice. Cdn J Diabetes Care, meeting suppl, Oct 2001 (abstract)

The Case of the Exploding Cop. Diabetes Monitor 1998

E Coli H-157 in Nursing Home Patients. J Inf Dis 1992

One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA,2007 Mar 21;297(11):1197-206.

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA,2006 Jan 11;295(2):180-9.

Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting. Int J Cardiol, 2006 Oct 10;112(3):302-7. Epub 2005 Dec 1.

Rosiglitazone in family practice, 6 years experience, Diabetes Medicine, Vol. 23, Issue s4, Page 300, December 2006, Poster P820

Effectiveness and Safety of Losarten in the Management of Essential Hypertension: A Prospective Cohort Study. Can J Diag, April 2007 24:4